Catalog record · Operations & Efficiency
Stage as of Mar 30, 2026 · historical report, not live reconfirmation.
Medical causality support for hospitalization-benefit adjudication
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 29, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Daido and Cinnamon AI developed a model using claims manuals and medical information to help assess whether a current disease is causally related to earlier claims and whether hospital days should be aggregated. The release says roughly 70% of cases previously referred to internal doctors could be handled with this support.
- Reported stage
- Announced
- Technology
- Other supported technology
- Business function
- Not assessed
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 29, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Implementation announced 2026-03-30; operational start scheduled 2026-04-01; no subsequent operating-status check. Status as of 2026-03-30.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Faster payments and annual time savings are expected benefits, not verified realized outcomes. The 70% is the carrier's claim about previously doctor-referred cases, not all claims. The first-year 1,800-hour estimate is prospective; no measured payout-time or error-rate series disclosed. The 70% is the carrier's claim about previously doctor-referred cases, not all claims. The first-year 1,800-hour estimate is prospective; no measured payout-time or error-rate series disclosed.
Potential FS application · inferred
Life-insurance claims medical-evidence interpretation and specialist-referral triage.
Original industry: . Transfer limits: The 70% is the carrier's claim about previously doctor-referred cases, not all claims. The first-year 1,800-hour estimate is prospective; no measured payout-time or error-rate series disclosed.
Source register
- Industry-first AI Doctor for benefit-payment assessment (Japanese)daido-life.co.jp · opens in a new tab
Daido Life · issuer · full-text · Published 2026-03-30
Research lanes: insurance · Batch global-discovery-2026-10-29. Coverage and remaining gaps